Logan RP et al. |
Clarithromycin and omeprazole for Helicobacter pylori. |
1992 |
Lancet |
pmid:1353155
|
Hammerschlag MR et al. |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1324650
|
Paulsen P et al. |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome. |
1992 |
Chemotherapy |
pmid:1324831
|
Ruf B et al. |
Acquired resistance of MAI to clarithromycin. |
1992 |
Am. Rev. Respir. Dis. |
pmid:1533999
|
de Lalla F et al. |
Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1387303
|
Yajko DM |
In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? |
1992 |
Res. Microbiol. |
pmid:1455069
|
Brown BA et al. |
Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416891
|
Biehle J and Cavalieri SJ |
In vitro susceptibility of Mycobacterium kansasii to clarithromycin. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1416897
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Sturgill MG and Rapp RP |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles. |
1992 |
Ann Pharmacother |
pmid:1421677
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Rehg JE |
Anti-cryptosporidial activity of macrolides in immunosuppressed rats. |
1991 Nov-Dec |
J. Protozool. |
pmid:1667930
|
Hughes WT |
Macrolide-antifol synergism in anti-Pneumocystis carinii therapeutics. |
1991 Nov-Dec |
J. Protozool. |
pmid:1818149
|
De Punzio C et al. |
Isolation of Chlamydia trachomatis during IVF-ET. |
1991 Jul-Aug |
Acta Eur. Fertil. |
pmid:1844324
|
Cogo R et al. |
[Dynamics of sIgA concentration in bronchial secretions in patients with COBP treated with clarithromycin]. |
1991 Jan-Dec |
G Ital Chemioter |
pmid:1365564
|
Anderson G |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections. |
1991 |
J. Hosp. Infect. |
pmid:1684979
|
Davey PG |
The pharmacokinetics of clarithromycin and its 14-OH metabolite. |
1991 |
J. Hosp. Infect. |
pmid:1684980
|
|
Clarithro- and azithromycin--better erythromycins? |
1991 |
Drug Ther Bull |
pmid:1665125
|